VAERS Explorer
Back to explore

Report #2849731

Received Jul 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
37 yrs
State
CA
Recovered
Unknown
Vaccinated
May 6, 2025
Onset
May 6, 2025
Days to onset
0
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNKY018398RA
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNKY015760LA
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNKX022737LA

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

no symptoms reported; repeat dose 6/10/25; GARDASIL 9 was administered to a patient after product experienced a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 06-MAY-2025 (discrepancy, reported as 06-MAY-2026), the patient was vaccinated with human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection at a dose of 0.5 mL, lot #Y018398, expiration date: 04-NOV-2026, for prophylaxis (route of administration and anatomical location were not reported). The administered vaccine underwent temperature excursion prior to administration (30.0 F for 15 hours; no previous temperature excursions) (Product storage error). No symptoms reported (No adverse event). The report is invalid due to lack of the patient's identifiers. Follow-up information was received on 20-Jun-2025. The patient was a 37-year-old female. On 06-May-2025, the patient was vaccinated with the second dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) administered in the right deltoid. On an unspecified date, the patient was vaccinated with human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) lot #Y015760, expiration date: 10-Feb-2027, administered in the left deltoid. On an unspecified date, the patient was vaccinated with human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) lot #X022737, expiration date: 12-Apr-2026, administered in the left deltoid (all details regarding vaccination could not be captured due to illegible source document). The following narrative was reported: The refrigerator where the immunizations were stored was out of range the morning of [missing information due to illegible source document]; vaccine given temperature was in range however unsure of how many [missing information due to illegible source document]; there was a temperature excursion. Called manufacturer recommended for [missing information due to illegible source document] to repeat dose. The provider was informed and the patient was contacted. On 10-Jun-2025, the patient was vaccinated with the repeat dose (inappropriate schedule of product administration). The case was no longer considered to be invalid.; Sender's Comments: Priority : 5 , Is case serious : No , MNSC number : 02801226-02801218 , CLIC number : , ESTAR number : , IRMS number : 500UW00000aF2stYAC|20062025230039|5889 , Central date : 2025-06-21 , Classification : DMC, Attachment description : NSC Call , Safety case number : 2283569 , MNSC case number : 02801226 , MNSC interaction number : 02801218 , Integration log UniqueID : 500UW00000aF2stYAC|20062025230039|5889 , Service cloud CaseID : 500UW00000aF2stYAC